Pharma Equity Group A/S Class APharma Equity Group A/S Class APharma Equity Group A/S Class A

Pharma Equity Group A/S Class A

No trades
No trades

Compare with Pharma Equity Group A/S Class A


Market capitalization
‪96.98 M‬DKK
−0.0222DKK
‪−25.38 M‬DKK
0.00DKK
‪742.25 M‬
Beta (1Y)
0.16

Profile


CEO
Christian Henrik Tange
Headquarters
Hørsholm
Founded
2002
IPO date
Jun 25, 2003
ISIN
DK0061155009
FIGI
BBG000PRFV16
Identifiers
ISIN DK0061155009
CFI code
ESVUFN
Pharma Equity Group A/S operates as a biopharmaceutical group that develops the most effective local treatments for serious, acute and chronic inflammatory diseases. The company specializes in repositioning existing drugs and advancing selected candidates to clinical Phase II. It provides a cost-efficient and flexible development environment, enabling the rapid mobilization of relevant resources. The company was founded on September 20, 2002 and is headquartered in Horsholm, Denmark.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of PEG is 0.0790 DKK — it has decreased by −3.89% in the past 24 hours. Watch Pharma Equity Group A/S Class A stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXCOP exchange Pharma Equity Group A/S Class A stocks are traded under the ticker PEG.
PEG stock has fallen by −5.95% compared to the previous week, the month change is a 17.56% rise, over the last year Pharma Equity Group A/S Class A has showed a −34.17% decrease.
PEG reached its all-time high on Apr 4, 2011 with the price of 60.0000 DKK, and its all-time low was 0.0602 DKK and was reached on Jun 1, 2026. View more price dynamics on PEG chart.
See other stocks reaching their highest and lowest prices.
PEG stock is 4.05% volatile and has beta coefficient of 0.16. Track Pharma Equity Group A/S Class A stock price on the chart and check out the list of the most volatile stocks — is Pharma Equity Group A/S Class A there?
Today Pharma Equity Group A/S Class A has the market capitalization of ‪96.98 M‬, it has increased by 0.69% over the last week.
Yes, you can track Pharma Equity Group A/S Class A financials in yearly and quarterly reports right on TradingView.
PEG net income for the last half-year is ‪−15.89 M‬ DKK, while the previous report showed ‪−9.49 M‬ DKK of net income which accounts for 0.00% change. Track more Pharma Equity Group A/S Class A financial stats to get the full picture.
No, PEG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PEG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pharma Equity Group A/S Class A stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pharma Equity Group A/S Class A technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pharma Equity Group A/S Class A stock shows the sell signal. See more of Pharma Equity Group A/S Class A technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.